Sandoz Drops Generic Mirapex Plans For Now

By Brendan Pierson · July 30, 2010, 6:46 PM EDT

Sandoz Inc. has given up its fight to market a generic version of Boehringer Ingelheim International GmbH's Parkinson's drug Mirapex before Boehringer's patent on the drug expires in October in light...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Recent Articles By Brendan

August 11, 2010
J&J Faces Inquiries From State AGs Over Recalls
August 10, 2010
FTC May Have Spilled Watson's Secrets, CEO Says
August 06, 2010
St. Vincent's Moves To Sell Off 2 Nursing Homes
August 04, 2010
New Trial Ordered In $4M Wyeth Retaliation Suit
August 03, 2010
Eisai Calls For Tough Inequitable Conduct Standard
July 20, 2010
AMA, Others Sue To Preserve Claims Against Wellpoint
July 19, 2010
5th Circ. Shoots Down Challenge To Vioxx Settlement
July 14, 2010
Ex-HealthSouth CEO Seeks Early Release From Prison
July 07, 2010
Skilled Healthcare Hit With $671M Verdict
June 23, 2010
Trasylol Plaintiffs Lose Bid To Use Expert